Open AccessElevated serum levels of interleukin-37 correlate with poor prognosis in gastric cancer
Author(s) -
Yan Zhang,
Min Tang,
Xiao Ge Wang,
Jin Gu,
Li Na Zhou,
Jun Jin,
Ping Li,
Li Qiang Wang,
Min Bin Chen
Publication year - 2019
Publication title -
revista española de enfermedades digestivas/revista española de enfermedades digestivas
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.331
H-Index - 38
eISSN - 2340-4167
pISSN - 1130-0108
DOI - 10.17235/reed.2019.6460/2019
Subject(s) - medicine , gastroenterology , cancer , hazard ratio , multivariate analysis , univariate analysis , stage (stratigraphy) , oncology , confidence interval , paleontology , biology
interleukin-37 (IL-37) is as a natural suppressor of the innate inflammatory and immune responses. It has also been reported to be involved in carcinogenesis and metastasis. The present case-control study was designed to investigate the role of serum levels of IL-37 in patients with gastric cancer.